(Q37707267)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222150%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

review article

1 reference

title

Urinary biomarkers involved in type 2 diabetes: a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222150%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222150%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Bradley J. Walsh

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222150%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Agnès Matheson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222150%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Judith Flanagan

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222150%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 March 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222150%20AND%20SRC:MED&resulttype=core&format=json

Diabetes - Metabolism: Research and Reviews

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222150%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222150%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222150%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

150-171

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222150%20AND%20SRC:MED&resulttype=core&format=json

Screening for type 2 diabetes: literature review and economic modelling

19 January 2020

cites work

1 reference

Tests of glycemia for the diagnosis of type 2 diabetes mellitus

21 January 2018

1 reference

Urinary enzyme measurements as early indicators of renal insult in type 2 diabetes

21 January 2018

1 reference

Microalbuminuria in type 2 diabetes: an independent predictor of cardiovascular mortality.

21 January 2018

1 reference

The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study

21 January 2018

1 reference

Serum cystatin C, enzymuria, tubular proteinuria and early renal insult in type 2 diabetes

21 January 2018

1 reference

Damage of tubule cells in diabetic nephropathy type 2: urinary N-acetyl-beta-D-glucosaminidasis and gamma-glutamil-transferasis.

21 January 2018

1 reference

Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics

21 January 2018

1 reference

Increased Incidence of Coronary Atherosclerosis in Type 2 Diabetes Mellitus: Mechanisms and Management

21 January 2018

1 reference

Platelet volume and urinary prostanoid metabolites in non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

Transferrinuria in Type 2 Diabetes: The Effect of Glycaemic Control

21 January 2018

1 reference

Practical points in urinary proteomics

21 January 2018

1 reference

7 January 2021

Urinary proteomics: towards biomarker discovery, diagnostics and prognostics

1 reference

7 January 2021

Urine proteomics: the present and future of measuring urinary protein components in disease

1 reference

7 January 2021

Urine in clinical proteomics

1 reference

7 January 2021

Diabetic microvascular complications and growth factors.

1 reference

7 January 2021

Follow-up study on urinary type IV collagen in patients with early stage diabetic nephropathy

1 reference

7 January 2021

Diabetic nephropathy: mechanisms of renal disease progression

1 reference

7 January 2021

Urinary protein excretion in Type 2 diabetes with complications

1 reference

7 January 2021

Prospective evaluation of urinary N-acetyl-beta-D-glucosaminidase with respect to macrovascular disease in elderly type 2 diabetic patients

1 reference

7 January 2021

Type IV collagen as an early marker for diabetic nephropathy in non-insulin-dependent diabetes mellitus

1 reference

7 January 2021

Markers of diabetic nephropathy

1 reference

7 January 2021

Enzymuria in non-insulin-dependent diabetic patients: signs of tubular cell dysfunction

1 reference

7 January 2021

Time to abandon microalbuminuria?

1 reference

7 January 2021

Does microalbuminuria predict diabetic nephropathy?

1 reference

7 January 2021

Ambulatory blood pressure in the transition from normo- to microalbuminuria. A longitudinal study in IDDM patients

1 reference

7 January 2021

Early markers of the renal complications of insulin dependent diabetes mellitus.

1 reference

7 January 2021

The predictive value of microalbuminuria in IDDM. A five-year follow-up study

1 reference

7 January 2021

Quantitative assessment of urinary protein and enzyme excretion--a diagnostic programme for the detection of renal involvement in type I diabetes mellitus

1 reference

7 January 2021

Urinary Transferrin Excretion in Type 1 (Insulin-dependent) Diabetes Mellitus

1 reference

7 January 2021

A Six-year Follow-up of the Relationship Between N-Acetyl-β-glucosaminidase and Albuminuria in Relation to Retinopathy

1 reference

7 January 2021

Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type 1 diabetes. Oxford Regional Prospective Study Group.

1 reference

7 January 2021

Urinary excretion of plasma proteins in diabetic subjects. Increased excretion of kappa light chains in diabetic patients with and without proliferative retinopathy

1 reference

7 January 2021

Microalbuminuria as a marker of cardiovascular risk in patients with type 2 diabetes

1 reference

7 January 2021

Clinical practice. Nephropathy in patients with type 2 diabetes

1 reference

7 January 2021

The association of non-insulin-dependent diabetes mellitus and hypertension with urinary excretion of albumin and transferrin

1 reference

7 January 2021

Microalbuminuria and diabetic complications in Chinese non-insulin-dependent diabetic patients: a prospective study

1 reference

7 January 2021

Contribution of hyperglycemia and renal damage to urinary C-peptide clearance in non-insulin-dependent diabetic patients

1 reference

7 January 2021

Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes

1 reference

7 January 2021

Albuminuria as a marker of the risk of developing type 2 diabetes in non-diabetic Aboriginal Australians

1 reference

7 January 2021

Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study

1 reference

7 January 2021

The clinical characteristics of normoalbuminuric renal insufficiency in Korean type 2 diabetic patients: a possible early stage renal complication.

1 reference

7 January 2021

Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study

1 reference

7 January 2021

Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL.

1 reference

7 January 2021

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

1 reference

7 January 2021

Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus?

1 reference

7 January 2021

Increased urinary albumin excretion is a marker of risk for retinopathy and coronary heart disease in patients with type 2 diabetes mellitus

1 reference

7 January 2021

Albuminuria is a marker of increasing intracranial and extracranial vascular involvement in Type 2 diabetic Chinese patients.

1 reference

7 January 2021

The prognostic value of albuminuria for the development of cardiovascular disease and retinopathy: a 5-year follow-up of 451 patients with type 2 diabetes mellitus.

1 reference

7 January 2021

Albuminuria and Poor Glycemic Control Predict Mortality in NIDDM

1 reference

7 January 2021

C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk

1 reference

7 January 2021

Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.

1 reference

7 January 2021

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy

1 reference

7 January 2021

Microalbuminuria is closely related to diabetic macroangiopathy

1 reference

7 January 2021

Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients

1 reference

7 January 2021

Influence of glycemic control and hypertension on urinary microprotein excretion in non-insulin-dependent diabetes mellitus

1 reference

7 January 2021

Urinary excretion of angiotensin-converting enzyme in NIDDM patients with nephropathy

1 reference

7 January 2021

Orosomucoid in urine predicts cardiovascular and over-all mortality in patients with Type II diabetes

1 reference

7 January 2021

Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus

1 reference

7 January 2021

Prospective study of microalbuminuria as predictor of mortality in NIDDM

1 reference

7 January 2021

Microalbuminuria and cardiovascular risk factors in type 2 diabetes mellitus

1 reference

7 January 2021

Microalbuminuria presents the same vascular risk as overt CVD in type 2 diabetes

1 reference

7 January 2021

Urinary albumin levels in the normal range determine arterial wall thickness in adults with Type 2 diabetes: a FIELD substudy.

1 reference

7 January 2021

Homocysteine and other biochemical parameters in Type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy

1 reference

7 January 2021

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

1 reference

7 January 2021

Abnormal Albuminuria as a Predictor of Mortality and Renal Impairment in Chinese Patients With NIDDM

1 reference

7 January 2021

Relationship between serum 1,5-anhydroglucitol and urinary excretion of N-acetylglucosaminidase and albumin determined at onset of NIDDM with 3-year follow-up.

1 reference

7 January 2021

Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns

1 reference

7 January 2021

Clinical significance of microalbuminuria in Japanese subjects with non-insulin-dependent diabetes

1 reference

7 January 2021

Correlation of microalbumin and sialic acid with anthropometric variables in type 2 diabetic patients with and without nephropathy

1 reference

7 January 2021

Determination of urinary enzymes as a marker of early renal damage in diabetic patients.

1 reference

7 January 2021

Clinical significance of urinary enzymes in diabetic nephropathy

1 reference

7 January 2021

Renal proximal and distal tubular function is attenuated in diabetes mellitus type 1 as determined by the renal excretion of alpha 1-microglobulin and Tamm-Horsfall protein

1 reference

7 January 2021

Tubular dysfunction and microalbuminuria in insulin dependent diabetes

1 reference

7 January 2021

Urinary transforming growth factor-beta1 and alpha1-microglobulin in children and adolescents with type 1 diabetes

1 reference

7 January 2021

Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage

1 reference

7 January 2021

Urinary alpha1-microglobulin as a marker of nephropathy in type 2 diabetic Asian subjects in Singapore

1 reference

7 January 2021

Proteomic identification of urinary biomarkers of diabetic nephropathy

1 reference

7 January 2021

Endothelial dysfunction in geriatric diabetic patients: the role of microalbuminuria in elderly type 2 diabetic patients? A randomized controlled study

1 reference

7 January 2021

Proteinuria and enzymuria in non-insulin-dependent diabetics

1 reference

7 January 2021

Beta 2-glycoprotein-1 (apolipoprotein H) excretion and renal tubular malfunction in diabetic patients without clinical proteinuria

1 reference

7 January 2021

Urinary excretion of kappa light chains in patients with diabetes mellitus

1 reference

7 January 2021

Urinary PGDS levels are associated with vascular injury in type 2 diabetes patients.

1 reference

7 January 2021

Dissociation between urinary pyrraline and pentosidine concentrations in diabetic patients with advanced nephropathy

1 reference

7 January 2021

Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients

1 reference

7 January 2021

Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy

1 reference

7 January 2021

Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy

1 reference

7 January 2021

Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus

1 reference

7 January 2021

Parallel increase in urinary excretion rates of immunoglobulin G, ceruloplasmin, transferrin, and orosomucoid in normoalbuminuric type 2 diabetic patients

1 reference

7 January 2021

Urinary excretion rate of ceruloplasmin in non-insulin-dependent diabetic patients with different stages of nephropathy

1 reference

7 January 2021

Reduced Urinary Excretion of Epidermal Growth Factor in Incipient and Overt Diabetic Nephropathy

1 reference

7 January 2021

Early urinary changes in Tamm-Horsfall protein and epidermal growth factor in diabetic children

1 reference

7 January 2021

Excretion of epidermal growth factor (EGF) in diabetes

1 reference

7 January 2021

Excretion of urinary epidermal growth factor in non-insulin dependent diabetes mellitus

1 reference

7 January 2021

Urinary excretion of Tamm-Horsfall protein and epidermal growth factor in chronic nephropathy

1 reference

7 January 2021

Urinary excretion of human epidermal growth factor in the various stages of diabetic nephropathy

1 reference

7 January 2021

Haemostatic measures in type 2 diabetic patients with microalbuminuria

1 reference

7 January 2021

A longitudinal evaluation of urinary glycosaminoglycan excretion in normoalbuminuric type 1 diabetic patients

1 reference

7 January 2021

Altered distribution of urinary glycosaminoglycans in diabetic subjects

1 reference

7 January 2021

Size and charge selectivity of the glomerular filter in patients with insulin-dependent diabetes mellitus: urinary immunoglobulins and glycosaminoglycans

1 reference

7 January 2021

Urinary sulphated glycosaminoglycans and Tamm-Horsfall protein in type 1 diabetic patients

1 reference

7 January 2021

Insulin-dependent diabetes mellitus and glycosaminoglycans

1 reference

7 January 2021

Diabetic microangiopathy and urinary glycosaminoglycans

1 reference

7 January 2021

Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression

1 reference

7 January 2021

Urinary glycosaminoglycan excretion in NIDDM subjects: its relationship to albuminura

1 reference

7 January 2021

Clinical applications of immunoglobulin free light chain estimations

1 reference

7 January 2021

Quantitative assessment of serum and urinary polyclonal free light chains in patients with type II diabetes: an early marker of diabetic kidney disease?

1 reference

7 January 2021

Serum and urinary concentrations of type IV collagen and laminin as a marker of microangiopathy in diabetes

1 reference

7 January 2021

Clinical significance of urinary laminin P1 in diabetic patients

1 reference

7 January 2021

Urinary prostaglandin D synthase (beta-trace) excretion increases in the early stage of diabetes mellitus

1 reference

7 January 2021

Urinary excretions of lipocalin-type prostaglandin D synthase predict renal injury in type-2 diabetes: a cross-sectional and prospective multicentre study

1 reference

7 January 2021

Markers of renal tubular dysfunction measured annually do not predict risk of microalbuminuria in the first few years after diagnosis of Type I diabetes

1 reference

7 January 2021

Further evidence for tubular dysfunction in insulin dependent diabetes

1 reference

7 January 2021

Effect of control of blood glucose on urinary excretion of N-acetyl-beta-D-glucosaminidase in elderly type 2 diabetes mellitus

1 reference

7 January 2021

Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination.

1 reference

7 January 2021

Urinary angiotensin-converting enzyme activity in type 2 diabetes mellitus: its relationship to diabetic nephropathy

1 reference

7 January 2021

Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases

1 reference

7 January 2021

Elevated glycine betaine excretion in diabetes mellitus patients is associated with proximal tubular dysfunction and hyperglycemia

1 reference

7 January 2021

Urinary excretion of n-acetyl-beta-D-glucosaminidase and retinol binding protein as alternative indicators of nephropathy in patients with type 1 diabetes mellitus.

1 reference

7 January 2021

Diabetic retinopathy related to degree of albuminuria and tubular (low molecular weight) proteinuria in insulin-dependent (type I) diabetes mellitus

1 reference

7 January 2021

Increased urinary excretion of the retinol-binding protein in insulin-dependent diabetes mellitus in the absence of microalbuminuria

1 reference

7 January 2021

Retinol, alpha-tocopherol and carotenoids in diabetes.

1 reference

7 January 2021

Changes in urinary retinol binding protein excretion and other indices of renal tubular damage in patients with non-insulin dependent diabetes

1 reference

7 January 2021

Tamm-Horsfall-Protein excretion as a marker of ascending limb transport indicates early renal tubular damage in diabetes mellitus type I

1 reference

7 January 2021

Proteomic analysis for the assessment of diabetic renal damage in humans

1 reference

7 January 2021

Urinary transferrin and albumin concentrations in patients with type 1 diabetes and normal controls: the search for the first protein lost

1 reference

7 January 2021

Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes

1 reference

7 January 2021

Increased collagen IV excretion in diabetes. A marker of compromised filtration function

1 reference

7 January 2021

Urinary type IV collagen as a marker for early diabetic nephropathy

1 reference

7 January 2021

Significance of urinary type IV collagen in patients with diabetic nephropathy using a highly sensitive one-step sandwich enzyme immunoassay

1 reference

7 January 2021

Serum or urinary concentration of type IV collagen in diabetics

1 reference

7 January 2021

Urinary excretion of type IV collagen as a specific indicator of the progression of diabetic nephropathy

1 reference

7 January 2021

Molecular mechanism of diabetic nephropathy

1 reference

7 January 2021

Renal albumin absorption in physiology and pathology

1 reference

7 January 2021

Microalbuminuria: An Early Marker of Renal Involvement in Diabetes

1 reference

7 January 2021

Update on microalbuminuria as a biomarker in renal and cardiovascular disease

1 reference

7 January 2021

Microalbuminuria as an early marker for cardiovascular disease

1 reference

7 January 2021

Blood pressure and cardiac autonomic function in relation to risk factors and treatment perspectives in Type 1 diabetes

1 reference

7 January 2021

Current issues in measurement and reporting of urinary albumin excretion

1 reference

7 January 2021

Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes

1 reference

7 January 2021

Lowering the threshold for defining microalbuminuria: effects of a lifestyle-metformin intervention in obese "normoalbuminuric" non-diabetic subjects

1 reference

7 January 2021

Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.

1 reference

7 January 2021

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

1 reference

7 January 2021

Human transferrin: cDNA characterization and chromosomal localization

1 reference

7 January 2021

Assessment of renal function: selected developments

1 reference

7 January 2021

Mechanisms for oxidative stress in diabetic cardiovascular disease

1 reference

7 January 2021

The pathobiology of diabetic complications: a unifying mechanism

1 reference

7 January 2021

Biochemistry and molecular cell biology of diabetic complications

1 reference

7 January 2021

Oxidative stress, glucose metabolism, and the prevention of type 2 diabetes: pathophysiological insights

1 reference

7 January 2021

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

7 January 2021

Metabolic disorders in diabetes mellitus: impact of mitochondrial function and oxidative stress on diabetes and its complications

1 reference

7 January 2021

Glycoxidation, and protein and DNA oxidation in patients with diabetes mellitus

1 reference

7 January 2021

New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus.

1 reference

7 January 2021

Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes

1 reference

7 January 2021

Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients

1 reference

7 January 2021

Urinary 8-hydroxydeoxyguanosine levels in diabetic retinopathy patients.

1 reference

7 January 2021

Urinary excretion of 8-oxo-7, 8-dihydro-2'-deoxyguanosine as a predictor of the development of diabetic nephropathy

1 reference

7 January 2021

Oxidative DNA damage in diabetes mellitus: its association with diabetic complications

1 reference

7 January 2021

Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics.

1 reference

7 January 2021

Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy

1 reference

7 January 2021

Pentosidine and increased fracture risk in older adults with type 2 diabetes

1 reference

7 January 2021

Increased Urinary Levels of Pentosidine, Pyrraline and Acrolein Adduct in Type 2 Diabetes

1 reference

7 January 2021

Oxidative stress and cellular stress response in diabetic nephropathy.

1 reference

7 January 2021

The Maillard protein cross-link pentosidine in urine from diabetic patients

1 reference

7 January 2021

Urinary oxidative stress markers in young patients with type 1 diabetes

1 reference

7 January 2021

Formation of advanced glycosylation end products and oxidative stress in young patients with type 1 diabetes

1 reference

7 January 2021

Lipid peroxidation in early type 1 diabetes mellitus is unassociated with oxidative damage to DNA.

1 reference

7 January 2021

Oxidative stress markers in plasma and urine of prepubertal patients with type 1 diabetes mellitus

1 reference

7 January 2021

F2 isoprostane is already increased at the onset of type 1 diabetes mellitus: effect of glycemic control

1 reference

7 January 2021

Divergence in plasmatic and urinary isoprostane levels in type 2 diabetes

1 reference

7 January 2021

Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress

1 reference

7 January 2021

Urinary F2-isoprostanes are not associated with increased risk of type 2 diabetes

1 reference

7 January 2021

Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes.

1 reference

7 January 2021

Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration.

1 reference

7 January 2021

Oxidative stress and antioxidant status in type 1 diabetes mellitus

1 reference

7 January 2021

Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion

1 reference

7 January 2021

Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus

1 reference

7 January 2021

Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population

1 reference

7 January 2021

Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus.

1 reference

7 January 2021

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

1 reference

7 January 2021

Serum and urine malondialdehyde levels in NIDDM patients with and without hyperlipidemia

1 reference

7 January 2021

Plasma and urine malondialdehyde levels in non-insulin-dependent diabetic patients with and without microalbuminuria

1 reference

7 January 2021

Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes.

1 reference

7 January 2021

Urinary pyrraline as a biochemical marker of non-oxidative Maillard reactions in vivo

1 reference

7 January 2021

Renal catabolism of advanced glycation end products: the fate of pentosidine

1 reference

7 January 2021

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

7 January 2021

Pathogenic perspectives for the role of inflammation in diabetic nephropathy.

1 reference

7 January 2021

Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes

1 reference

7 January 2021

An immune origin of type 2 diabetes?

1 reference

7 January 2021

Type 2 diabetes: principles of pathogenesis and therapy

1 reference

7 January 2021

Immune mechanisms in atherosclerosis

1 reference

7 January 2021

Diabetes mellitus and macrovascular disease: mechanisms and mediators

1 reference

7 January 2021

Inflammation and atherosclerosis

1 reference

7 January 2021

Cardiovascular complications in diabetes: targets and interventions

1 reference

7 January 2021

Diabetes mellitus as a prothrombotic condition

1 reference

7 January 2021

Endothelial function, inflammation, and prognosis in cardiovascular disease

1 reference

7 January 2021

Hyperglycemia and the pathobiology of diabetic complications

1 reference

7 January 2021

How hyperglycemia promotes atherosclerosis: molecular mechanisms

1 reference

7 January 2021

Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies

1 reference

7 January 2021

The AGE/RAGE axis in diabetes-accelerated atherosclerosis.

1 reference

7 January 2021

Introduction: Symposium on diabetes, inflammation and cardiovascular disease

1 reference

7 January 2021

Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy

1 reference

7 January 2021

Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy

1 reference

7 January 2021

Adipocytokines are associated with renal function in patients with normal range glomerular filtration rate and type 2 diabetes

1 reference

7 January 2021

Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications.

1 reference

7 January 2021

Urinary endothelin in adolescents and young adults with insulin-dependent diabetes mellitus: relation to urinary albumin, blood pressure, and other factors

1 reference

7 January 2021

The correlation of plasma and urine endothelin-1 with the severity of nephropathy in Chinese patients with type 2 diabetes

1 reference

7 January 2021

Role of plasma and urinary endothelin-1 in early diabetic and hypertensive nephropathy

1 reference

7 January 2021

Increased urinary endothelin-1-like immunoreactivity excretion in NIDDM patients with albuminuria

1 reference

7 January 2021

Activation of Coagulation in Diabetes Mellitus in Relation to the Presence of Vascular Complications

1 reference

7 January 2021

Serum and urinary cytokine homeostasis and renal tubular function in children with type 1 diabetes mellitus

1 reference

7 January 2021

Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics

1 reference

7 January 2021

Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.

1 reference

7 January 2021

Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy

1 reference

7 January 2021

Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.

1 reference

7 January 2021

MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy

1 reference

7 January 2021

Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy

1 reference

7 January 2021

Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy.

1 reference

7 January 2021

Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus

1 reference

7 January 2021

Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy

1 reference

7 January 2021

Serum and urinary nitrites and nitrates and Doppler sonography in children with diabetes

1 reference

7 January 2021

Serum and urinary nitric oxide in Type 2 diabetes with or without microalbuminuria: relation to glomerular hyperfiltration

1 reference

7 January 2021

Nitric oxide system is involved in glomerular hyperfiltration in Japanese normo- and micro-albuminuric patients with type 2 diabetes

1 reference

7 January 2021

Orosomucoid in urine is a powerful predictor of cardiovascular mortality in normoalbuminuric patients with type 2 diabetes at five years of follow-up

1 reference

7 January 2021

Acute-phase proteins and microalbuminuria among patients with type 2 diabetes

1 reference

7 January 2021

Increased urinary orosomucoid excretion is not related to impaired renal function in patients with type 2 diabetes

1 reference

7 January 2021

Increased urinary orosomucoid excretion: a proposed marker for inflammation and endothelial dysfunction in patients with type 2 diabetes

1 reference

7 January 2021

Urinary transforming growth factor-beta 1 in various types of nephropathy

1 reference

7 January 2021

Transforming growth factor beta at clinical onset of Type 1 diabetes mellitus. A pilot study

1 reference

7 January 2021

Increased renal production of transforming growth factor-beta1 in patients with type II diabetes

1 reference

7 January 2021

Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy

1 reference

7 January 2021

Transforming growth factor beta activity in urine of patients with type 2 diabetes and diabetic nephropathy.

1 reference

7 January 2021

Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up

1 reference

7 January 2021

Elevated serum and urinary thrombomodulin levels in patients with non-insulin-dependent diabetes mellitus

1 reference

7 January 2021

Mechanisms of elevation of serum and urinary concentrations of soluble thrombomodulin in diabetic patients: possible application as a marker for vascular endothelial injury

1 reference

7 January 2021

Clinical significance of measurements of urinary and serum thrombomodulins in patients with non-insulin-dependent diabetes mellitus.

1 reference

7 January 2021

Thromboxane biosynthesis and platelet function in type I diabetes mellitus

1 reference

7 January 2021

Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications

1 reference

7 January 2021

Urinary thromboxane A2/prostacyclin balance reflects the pathological state of a diabetic

1 reference

7 January 2021

Increased renal TXA2 synthesis in diabetes mellitus: simultaneous determination of urinary TXB2 and 2,3-dinor-TXB2

1 reference

7 January 2021

Thromboxane biosynthesis and platelet function in type II diabetes mellitus

1 reference

7 January 2021

The activity of N-acetyl-beta-D-glucosaminidase and tumor necrosis factor-alpha at early stage of diabetic retinopathy development in type 1 diabetes mellitus children

1 reference

7 January 2021

Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus

1 reference

7 January 2021

Vascular Endothelial Growth Factor in Diabetic Nephropathy

1 reference

7 January 2021

Do urinary levels of vascular endothelial growth factor predict proliferative retinopathy?

1 reference

7 January 2021

Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus

1 reference

7 January 2021

Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy.

1 reference

7 January 2021

Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus

1 reference

7 January 2021

Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan

1 reference

7 January 2021

YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance.

1 reference

7 January 2021

Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia

1 reference

7 January 2021

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

1 reference

7 January 2021

Biochemical changes in a 100 km run: Proteins in serum and urine

1 reference

7 January 2021

Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy

1 reference

7 January 2021

Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis

1 reference

7 January 2021

Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention

1 reference

7 January 2021

Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients

1 reference

7 January 2021

Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats

1 reference

7 January 2021

Mechanism of albuminuria associated with cardiovascular disease and kidney disease

1 reference

7 January 2021

Increased plasma levels of endothelin 1 and von Willebrand factor in patients with type 2 diabetes and dyslipidemia.

1 reference

7 January 2021

Role for thromboxane A2 from glomerular thrombi in nephropathy with type 2 diabetic rats

1 reference

7 January 2021